Work

P142 Subcutaneously administered golimumab induction therapy improves health states measured by EQ-5D in patients with moderately to severely active ulcerative colitis: results from PURSUIT-SC

Year: 2013

Type: conference-abstract

Source: Journal of Crohn s and Colitis

DOI: 10.1016/s1873-9946(13)60164-6

Authors: P. Gibson, B. Feagan, C. Marano, R. Strauss, C. Han, J. Johanns, H. Zhang, C. Guzzo, J.-F. Colombel, W. Reinisch, J. Collins, G. Jarnerot, P. Rutgeerts, W. Sandborn

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1968402252

Cites:

Cited by: 2

Related to: 10